155 related articles for article (PubMed ID: 11869402)
1. Growth and adrenal suppression in asthmatic children on moderate to high doses of fluticasone propionate.
Wong JY; Zacharin MR; Hocking N; Robinson PJ
J Paediatr Child Health; 2002 Feb; 38(1):59-62. PubMed ID: 11869402
[TBL] [Abstract][Full Text] [Related]
2. Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids.
Kannisto S; Korppi M; Remes K; Voutilainen R
J Clin Endocrinol Metab; 2000 Feb; 85(2):652-7. PubMed ID: 10690871
[TBL] [Abstract][Full Text] [Related]
3. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part II. Safety aspects of therapy with fluticasone propionate in asthmatic children].
Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
Pol Merkur Lekarski; 2004; 17 Suppl 2():11-8. PubMed ID: 15688664
[TBL] [Abstract][Full Text] [Related]
4. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients.
Casale TB; Nelson HS; Stricker WE; Raff H; Newman KB
Ann Allergy Asthma Immunol; 2001 Nov; 87(5):379-85. PubMed ID: 11730179
[TBL] [Abstract][Full Text] [Related]
5. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.
Clark DJ; Lipworth BJ
Thorax; 1997 Jan; 52(1):55-8. PubMed ID: 9039246
[TBL] [Abstract][Full Text] [Related]
6. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
Peden DB; Berger WE; Noonan MJ; Thomas MR; Hendricks VL; Hamedani AG; Mahajan P; House KW
J Allergy Clin Immunol; 1998 Jul; 102(1):32-8. PubMed ID: 9679845
[TBL] [Abstract][Full Text] [Related]
7. Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate.
Todd G; Dunlop K; McNaboe J; Ryan MF; Carson D; Shields MD
Lancet; 1996 Jul; 348(9019):27-9. PubMed ID: 8691927
[TBL] [Abstract][Full Text] [Related]
8. Nocturnal cortisol secretion in asthmatic patients after inhalation of fluticasone propionate.
Weiner P; Berar-Yanay N; Davidovich A; Magadle R
Chest; 1999 Oct; 116(4):931-4. PubMed ID: 10531155
[TBL] [Abstract][Full Text] [Related]
9. Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma.
Sim D; Griffiths A; Armstrong D; Clarke C; Rodda C; Freezer N
Eur Respir J; 2003 Apr; 21(4):633-6. PubMed ID: 12762348
[TBL] [Abstract][Full Text] [Related]
10. Safety of inhaled fluticasone propionate therapy for pediatric asthma - a systematic review.
Muley P; Shah M; Muley A
Curr Drug Saf; 2013 Jul; 8(3):186-94. PubMed ID: 23859431
[TBL] [Abstract][Full Text] [Related]
11. Short-term dose-response relationships for the relative systemic effects of oral prednisolone and inhaled fluticasone in asthmatic adults.
Wilson AM; Lipworth BJ
Br J Clin Pharmacol; 1999 Oct; 48(4):579-85. PubMed ID: 10583029
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
Harrison TW; Wisniewski A; Honour J; Tattersfield AE
Thorax; 2001 Mar; 56(3):186-91. PubMed ID: 11182010
[TBL] [Abstract][Full Text] [Related]
13. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis.
Lipworth BJ
Arch Intern Med; 1999 May; 159(9):941-55. PubMed ID: 10326936
[TBL] [Abstract][Full Text] [Related]
14. Skin bruising, adrenal function and markers of bone metabolism in asthmatics using inhaled beclomethasone and fluticasone.
Malo JL; Cartier A; Ghezzo H; Mark S; Brown J; Laviolette M; Boulet LP
Eur Respir J; 1999 May; 13(5):993-8. PubMed ID: 10414395
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effect of a large volume spacer on the systemic bioactivity of fluticasone propionate metered-dose inhaler.
Dempsey OJ; Wilson AM; Coutie WJ; Lipworth BJ
Chest; 1999 Oct; 116(4):935-40. PubMed ID: 10531156
[TBL] [Abstract][Full Text] [Related]
16. Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.
Nelson HS; Busse WW; deBoisblanc BP; Berger WE; Noonan MJ; Webb DR; Wolford JP; Mahajan PS; Hamedani AG; Shah T; Harding SM
J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):267-75. PubMed ID: 9949318
[TBL] [Abstract][Full Text] [Related]
17. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).
Hoekx JC; Hedlin G; Pedersen W; Sorva R; Hollingworth K; Efthimiou J
Eur Respir J; 1996 Nov; 9(11):2263-72. PubMed ID: 8947070
[TBL] [Abstract][Full Text] [Related]
18. Decreased morning serum cortisol levels in children with asthma treated with inhaled fluticasone propionate.
Eid N; Morton R; Olds B; Clark P; Sheikh S; Looney S
Pediatrics; 2002 Feb; 109(2):217-21. PubMed ID: 11826198
[TBL] [Abstract][Full Text] [Related]
19. Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function.
Lee DK; Bates CE; Currie GP; Cowan LM; McFarlane LC; Lipworth BJ
Ann Allergy Asthma Immunol; 2004 Sep; 93(3):253-8. PubMed ID: 15478385
[TBL] [Abstract][Full Text] [Related]
20. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children.
Clark DJ; Clark RA; Lipworth BJ
Thorax; 1996 Sep; 51(9):941-3. PubMed ID: 8984708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
